Skip to main content
Livermore
Livermore
ZHEN

Profund Advisors LLC

SEC CIK
0001129919
Latest filing
Aug 11, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by Profund Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q2 2026)
4,648
Value
$260.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RPRX by Profund Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,648$260.6K<0.1%−314−6.3%ReducedHolders
Q1 20264,962$238.0K<0.1%−1,562−23.9%ReducedHolders
Q4 20256,524$252.1K<0.1%−1,621−19.9%ReducedHolders
Q3 20258,145$287.4K<0.1%−2,477−23.3%ReducedHolders
Q2 202510,622$382.7K<0.1%−992−8.5%ReducedHolders
Q1 202511,614$361.5K<0.1%−4,128−26.2%ReducedHolders
Q4 202415,742$401.6K<0.1%−663−4.0%ReducedHolders
Q3 202416,405$464.1K<0.1%−404−2.4%ReducedHolders
Q2 202416,809$443.3K<0.1%−3,238−16.2%ReducedHolders
Q1 202420,047$608.8K<0.1%+1,753+9.6%AddedHolders
Q4 202318,294$513.9K<0.1%−2,123−10.4%ReducedHolders
Q3 202320,417$554.1K<0.1%+2,071+11.3%AddedHolders
Q2 202318,346$564.0K<0.1%+876+5.0%AddedHolders
Q1 202317,470$629.4K<0.1%−3,670−17.4%ReducedHolders
Q4 202221,140$835.5K0.1%+817+4.0%AddedHolders
Q3 202220,323$817.0K0.1%−3,264−13.8%ReducedHolders
Q2 202223,587$992.0K0.1%−1,043−4.2%ReducedHolders
Q1 202224,630$960.0K<0.1%−1,869−7.1%ReducedHolders
Q4 202126,499$1.06M<0.1%+426+1.6%AddedHolders
Q3 202126,073$942.0K<0.1%+18,634+250.5%AddedHolders
Q2 20217,439$305.0K<0.1%+754+11.3%AddedHolders
Q1 20216,685$292.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.